OLANZAPINE DEXCEL 20 MG

Country: Israel

Language: English

Source: Ministry of Health

Active ingredient:

OLANZAPINE 20 MG

Available from:

DEXCEL PHARMA TECHNOLOGIES LTD

ATC code:

N05AH03

Pharmaceutical form:

TABLETS

Administration route:

PER OS

Manufactured by:

DEXCEL LTD

Therapeutic group:

OLANZAPINE

Therapeutic indications:

Acute and maintenance treatment of schizophrenia. Olanzapine is indicated for the management of the manifestations of psychotic disorders. Olanzapine is indicated for the short-term treatment of acute manic episodes associated with Bipolar I Disorder. Prevention of recurrence in Bipolar Disorder: in patients whose manic episodes has responded to olanzapine treatment, olanzapine is indicated for the prevention of recurrence in patients with Bipolar Disorder. Combination therapy in Bipolar I Disorder: the combination of olanzapine with lithium or valproate is indicated for the short-term treatment of acute manic episodes associated with Bipolar I Disorder.

Authorization date:

2012-05-01